generic

(redirected from Generics)
Also found in: Dictionary, Thesaurus, Legal, Financial, Idioms, Encyclopedia, Wikipedia.

generic

 [jĕ-ner´ik]
1. pertaining to a genus.
2. nonproprietary; denoting a drug name not protected by a trademark, usually descriptive of the drug's chemical structure.

ge·ner·ic

(jĕ-ner'ik),
1. Relating to or denoting a genus.
2. General.
3. Characteristic or distinctive.
[L. genus (gener-), birth]

generic

/ge·ner·ic/ (jĕ-ner´ik)
1. pertaining to a genus.
2. nonproprietary; denoting a drug name not protected by a trademark, usually descriptive of the drug's chemical structure.

generic

(jə-nĕr′ĭk)
adj.
1. Biology Of or relating to a genus.
2.
a. Relating to or being a product that is sold or distributed without any brand name or without a widely known brand name, especially as a discount alternative to a name-brand product: generic soap.
b. Relating to or being the official nonproprietary name of a drug, under which it is licensed and identified by the manufacturer.
n.
A product or substance sold under or identified by a generic name.

ge·ner′i·cal·ly adv.
gen′e·ric′i·ty (jĕn′ə-rĭs′ĭ-tē), ge·ner·ic·ness n.

generic

[jəner′ik]
Etymology: L, genus, kind
1 pertaining to a genus.
2 pertaining to a substance, product, or drug that is not protected by trademark.
3 pertaining to the nontrademarked name assigned to a drug by the U.S. Adopted Names (USAN) Council.

non-proprietary

Referring to the name assigned by the United States Adopted Name Council (USAN) once a compound has demonstrated some therapeutic efficacy, and has been recognised as the drug’s official name.

ge·ner·ic

(jĕ-ner'ik)
1. Relating to or denoting a genus.
2. General.
3. Characteristic or distinctive.
[L. genus (gener-), birth]

generic

of or belonging to a genus.

generic

1. pertaining to a genus.
2. nonproprietary; denoting a drug name not protected by a trademark, usually descriptive of the drug's chemical structure.

generic pet food
commercially prepared pet foods without a brand name; usually of low cost and possibly of poor quality. High levels of calcium in generic dog foods have reportedly been the cause of copper, zinc and iodine deficiency in a syndrome called generic dog food disease.

Patient discussion about generic

Q. When will a generic brand of insulin be available? The cost of insulin seems to be way too high... And with the ever rising population of diabetics, you'd think some other companies would jump unto the bandwagon with a cheaper insulin... what's up with that?

A. Unfortunately, as long as Eli Lilly has an effective monopoly on the American market and docs continue to perscribe the latest "flavor" of insulin, the situation is unlikely to change. Personally, I refuse to use Lilly's products (use Novo Nordisk insulin instead) and am still using the regular and NPH I was using 20 years ago... Also, because Type I diabetes tends to affect children, parents are naturally always seeking the next new thing. Doesn't make for an environment conducive to cheaper alternatives, which is a real shame for us all.

More discussions about generic
References in periodicals archive ?
2 The US Generics Market: Revenue Forecast 2011-2021
circulated a proposal ("Scientific and Technical Principles for Fixed-Dose Combination Products") that appears to require major clinical trials for approving generic fixed-dose combinations for HIV, trials not required for similar approvals in the U.
The generic entry faces a major challenge in the "bundling of products" offered to the distribution channel.
Four California health plans, seeking to curb rapidly rising prescription drug costs, are prodding physicians to prescribe more generic medications instead of their brand name counterparts.
In an effort to control those costs, Blue Cross & Blue Shield of Illinois is looking at the prospect of paying pharmacists to check with physicians to see whether it would be appropriate to change prescriptions for brand-name drugs to generic drugs, said Robert Kieckhefer, a spokesman for the Illinois Blues.
Latin American governments seek to replace copycats with generic drug-makers.
For every percentage point of its members that have switched to Lovastatin, a generic cholesterol-lowering drug, the company saves around $300,000 a year.
So we will be trying to tie up many strings in the Burkina Faso Summit on Generics.
An insight into which branded and generics companies entered into authorized generics agreements in the US between 2004 and 2008.
Table 1: United Kingdom Generics Market Value: $ billion, 2000-2004
Table 1: France Generics Market Value: $ billion, 2000-2004